Indian journal of psychiatry · 2025
The crossroad of delirium, mania, and catatonia: A case series on delirious mania.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gangwal Riya, Nawale Vaibhav Sunil, Mudgal Varchasvi, Mathur Rahul
Аннотация
BACKGROUND: Delirious mania (DM) is a rare, life-threatening neuropsychiatric syndrome marked by the simultaneous presence of manic excitement, catatonia, and fluctuating consciousness. Although described extensively in Western literature, Indian reports remain limited.
CASES: Four patients admitted to a government mental hospital in Central India were retrospectively evaluated for clinical features, investigations, comorbidities, treatment, and outcomes. All had a prior diagnosis of bipolar disorder and presented with acute agitation, grandiosity, disorientation, and catatonic features; two had past DM episodes. Comorbid hypertension and metabolic disturbances were noted in two cases. All showed clinical improvement with lorazepam, sodium valproate, and atypical antipsychotics, while one required electroconvulsive therapy for full resolution. Symptom stabilization occurred within 7-14 days of targeted treatment. Ethical approval and informed consent procedures were duly followed.
CONCLUSION: DM should be considered in bipolar patients presenting with catatonia and delirium. Early recognition and multimodal treatment, including electroconvulsive therapy (ECT) when needed, ensure favorable outcomes.
CASES: Four patients admitted to a government mental hospital in Central India were retrospectively evaluated for clinical features, investigations, comorbidities, treatment, and outcomes. All had a prior diagnosis of bipolar disorder and presented with acute agitation, grandiosity, disorientation, and catatonic features; two had past DM episodes. Comorbid hypertension and metabolic disturbances were noted in two cases. All showed clinical improvement with lorazepam, sodium valproate, and atypical antipsychotics, while one required electroconvulsive therapy for full resolution. Symptom stabilization occurred within 7-14 days of targeted treatment. Ethical approval and informed consent procedures were duly followed.
CONCLUSION: DM should be considered in bipolar patients presenting with catatonia and delirium. Early recognition and multimodal treatment, including electroconvulsive therapy (ECT) when needed, ensure favorable outcomes.